|
ATXN3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.60310000052455E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.66970004068202E-09 |
| Normal-vs-Stage2 |
2.283800E-02 |
| Normal-vs-Stage3 |
2.469900E-02 |
| Normal-vs-Stage4 |
3.010700E-04 |
| Stage1-vs-Stage2 |
2.881400E-01 |
| Stage1-vs-Stage3 |
6.702400E-02 |
| Stage1-vs-Stage4 |
8.419200E-01 |
| Stage2-vs-Stage3 |
7.125800E-01 |
| Stage2-vs-Stage4 |
4.640400E-01 |
| Stage3-vs-Stage4 |
2.706600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.37440000070566E-08 |
| Normal-vs-AfricanAmerican |
2.11919999999477E-05 |
| Normal-vs-Asian |
8.375200E-01 |
| Caucasian-vs-AfricanAmerican |
9.668600E-01 |
| Caucasian-vs-Asian |
9.640000E-02 |
| AfricanAmerican-vs-Asian |
1.584800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.25359999550534E-08 |
| Normal-vs-Female |
4.858300E-02 |
| Male-vs-Female |
4.844000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.03930000000729E-06 |
| Normal-vs-Extreme_Weight |
1.27119981208068E-10 |
| Normal-vs-Obese |
1.361450E-03 |
| Normal-vs-Extreme_Obese |
2.229900E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.021000E-01 |
| Normal_Weight-vs-Obese |
1.661020E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.292400E-01 |
| Extreme_Weight-vs-Obese |
4.020700E-03 |
| Extreme_Weight-vs-Extreme_Obese |
6.379400E-01 |
| Obese-vs-Extreme_Obese |
3.391600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.672200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.86821000000004E-05 |
| Normal-vs-Age(61-80Yrs) |
1.16680000106228E-08 |
| Normal-vs-Age(81-100Yrs) |
4.38830000004664E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.804600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.088160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.277040E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.167600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.561700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.534600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.84919999710343E-08 |
| Normal-VS-Type2 PRCC |
1.55319999994852E-06 |
| Normal-VS-KIRP CIMP |
2.332400E-01 |
| Normal-VS-Unclassified PRCC |
3.814000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.607600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.461600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.424430E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.376970E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.782200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.383800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.44189999518841E-08 |
| Normal-vs-N1 |
2.837400E-01 |
| Normal-vs-N2 |
3.60729999999698E-05 |
| N0-vs-N1 |
1.061810E-02 |
| N0-vs-N2 |
9.453600E-02 |
| N1-vs-N2 |
2.370100E-02 |
|
|
